Oral Leukoplakia
What's New
Last Posted: May 25, 2024
- Genome-wide characterization of the mutational landscape of proliferative verrucous leukoplakia.
Camile S Farah, et al. Oral surgery, oral medicine, oral pathology and oral radiology 2024 0 - Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias.
Anne Anuhya, et al. Cytogenetic and genome research 2023 0 - The Microbiome of Potentially Malignant Oral Leukoplakia Exhibits Enrichment for Fusobacterium, Leptotrichia, Campylobacter, and Rothia Species.
Amer Abdrazak, et al. Frontiers in microbiology 2017 0 2391 - Factors affecting Clinical Outcomes after Treatment of Oral Leukoplakia with CO and Diode Laser.
Galletta Vivian, et al. The journal of contemporary dental practice 2017 0 (9) 775-780 - Detection of HPV in oral leukoplakia by brushing and biopsy: prospective study in an Italian cohort.
Della Vella Fedora, et al. Clinical oral investigations 2019 0 (5) 1845-1851 - Exome sequencing of oral leukoplakia and oral squamous cell carcinoma implicates DNA damage repair gene defects in malignant transformation.
Farah Camile S, et al. Oral oncology 2019 0 42-50 - Association between hyperglycemia and the malignant transformation of oral leukoplakia in China.
Li Jin, et al. Oral diseases 2020 0 (7) 1402-1413 - Chronic disease comorbidity in patients with oral leukoplakia: A matched case-control study.
Giudice Lance W, et al. Oral diseases 2020 0 (5) 894-902 - Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
Wils Leon J, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 0 (3) 602-613 - Association Between X-Ray Repair Cross-Complementing Group 1 Arg399Gln Polymorphism and Risk of Oral Leukoplakia: A Meta-analysis.
Wang Jiayi, et al. Genetic testing and molecular biomarkers 2021 0 (12) 781-787
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: